Progyny Stock Analysis


USD 43.64  1.76  3.88%   

The current price rise of Progyny may encourage investors to take a closer look at the company as it is trading at a share price of 43.64 on 785,600 in trading volume. The company executives may have good odds in positioning the company resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.45. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Progyny partners.
Please check Your Equity Center.
The Progyny stock analysis report makes it easy to digest most publicly released information about Progyny and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Progyny Stock analysis module also helps to analyze the Progyny price relationship with some important fundamental indicators such as market cap and management efficiency.

Progyny Stock Analysis Notes

About 97.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Progyny operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 311 people. To find out more about Progyny contact the company at 212 888 3124 or learn more at

Progyny Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Progyny's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Progyny or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Progyny is way too risky over 90 days horizon
Progyny appears to be risky and price may revert if volatility continues
Progyny has high likelihood to experience some financial distress in the next 2 years
Over 97.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Exercise or conversion by Anevski Peter of 16000 shares of Progyny subject to Rule 16b-3

Progyny Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 4.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Progyny's market, we take the total number of its shares issued and multiply it by Progyny's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Progyny Profitablity

Progyny's profitability indicators refer to fundamental financial ratios that showcase Progyny's ability to generate income relative to its revenue or operating costs. If, let's say, Progyny is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Progyny's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Progyny's profitability requires more research than a typical breakdown of Progyny's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 10.09 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 3.94 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.04.

Management Efficiency

The entity has return on total asset (ROA) of 3.6 % which means that it generated profit of $3.6 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 23.94 %, meaning that it created $23.94 on every $100 dollars invested by stockholders. Progyny management efficiency ratios could be used to measure how well progyny manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 18th of August 2022, Progyny holds the Risk Adjusted Performance of 0.0918, semi deviation of 3.63, and Coefficient Of Variation of 1476.29. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Progyny, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Progyny, which can be compared to its competitors. Please check Progyny variance and potential upside to decide if Progyny is priced some-what accurately, providing market reflects its current price of 43.64 per share. Given that Progyny has jensen alpha of 0.2575, we recommend you to check out Progyny's recent market performance to make sure the company can sustain itself at a future point.

Progyny Price Movement Analysis

The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Triangular Moving Average shows Progyny double smoothed mean price over a specified number of previous prices (i.e., averaged twice).

Progyny Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Progyny insiders, such as employees or executives, is commonly permitted as long as it does not rely on Progyny's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Progyny insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Progyny Predictive Daily Indicators

Progyny intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Progyny stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Progyny Forecast Models

Progyny time-series forecasting models is one of many Progyny's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Progyny's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Progyny Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Progyny prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Progyny shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Progyny. By using and applying Progyny Stock analysis, traders can create a robust methodology for identifying Progyny entry and exit points for their positions.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Progyny operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 311 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Progyny to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Sync Your Broker Now


Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module
Please check Your Equity Center. Note that the Progyny information on this page should be used as a complementary analysis to other Progyny's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Progyny Stock analysis

When running Progyny price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Progyny's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progyny. If investors know Progyny will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progyny listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Progyny is measured differently than its book value, which is the value of Progyny that is recorded on the company's balance sheet. Investors also form their own opinion of Progyny's value that differs from its market value or its book value, called intrinsic value, which is Progyny's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progyny's market value can be influenced by many factors that don't directly affect Progyny's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Progyny's value and its price as these two are different measures arrived at by different means. Investors typically determine Progyny value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progyny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.